Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics
| ISSN | 10849785, 15578852 |
|---|---|
| Country | United States |
| Publisher | Mary Ann Liebert Inc. |
| Subject Areas | Biochemistry, Genetics and Molecular Biology · Medicine · Pharmacology, Toxicology and Pharmaceutics |
| Publication Type | Journals |
| Active Years | 1996-ongoing |
| Competitiveness | 5. Slowest (12-24 months) |
| Publication Time | 2. Quick (1-3 months) |
| Website | Visit journal |
| JIF 2022–2023 | 2.400 |
| 2019-2020 SCR Rank | 4850 |
| 2020-2021 SCR Rank | 4675 |
Cancer Biotherapy and Radiopharmaceuticals is a peer-reviewed journal covering cutting-edge biotherapy and innovative investigations of methods to improve cancer therapy. Includes more selective delivery of drugs, biologicals, radiopharmaceuticals, or other agents, and advances in delivery instrumentation and technology, with the aim of increasing efficacy of therapy and/or decreasing toxicity or improving convenience of therapy. Topics include: • Pre-targeted cancer therapy • Clinical trials in cancer research • Antibody therapy and imaging • Tumor cell vaccines • Radioimmunotherapy • T-cell therapy • Molecular targeted therapy and imaging • Drug resistance
| Year | 2-Year IF | 3-Year IF | 4-Year IF |
|---|---|---|---|
| 2023 | 2.791 | 3.056 | 2.859 |
| 2022 | 3.725 | 3.441 | 3.227 |
| 2021 | 3.636 | 3.421 | 3.272 |
| 2020 | 2.420 | 2.582 | 2.542 |
| 2019 | 1.783 | 1.826 | 1.795 |
| 2018 | 1.726 | 1.773 | 1.743 |
| 2017 | 1.567 | 1.643 | 1.741 |
| 2016 | 1.689 | 2.018 | 1.990 |
| 2015 | 1.926 | 1.882 | 1.774 |
| 2014 | 2.042 | — | — |
| 2013 | 1.659 | — | — |
| 2012 | 2.006 | — | — |
| 2011 | 2.155 | — | — |
| 2010 | 2.196 | — | — |
| 2009 | 1.551 | — | — |
| 2008 | 1.349 | — | — |
| 2007 | 1.779 | — | — |
| 2006 | 1.911 | — | — |
| 2005 | 1.667 | — | — |
| 2004 | 1.250 | — | — |
| 2003 | 1.935 | — | — |
| 2002 | 1.540 | — | — |
| 2001 | 1.532 | — | — |
| 2000 | 0.875 | — | — |
Note: impact factor data for reference only.
SJR measures scientific influence, weighting citations by the prestige of the citing journal.
| Year | SJR Score |
|---|---|
| 2023 | 0.607 |
| 2022 | 0.650 |
| 2021 | 0.592 |
| 2020 | 0.716 |
| 2019 | 0.544 |
| 2018 | 0.545 |
| 2017 | 0.567 |
| 2016 | 0.694 |
| 2015 | 0.680 |
The H-Index measures both the productivity and citation impact of a journal's publications.
| Year | H-Index |
|---|---|
| 2023 | 68.000 |
| 2022 | 66.000 |
| 2021 | 63.000 |
| 2020 | 59.000 |